How comfortable are you to start integrating patient discussions on COVID-19 pre-emptive treatment within your pharmacy practice?
Do you think pre-emptive prescribing will improve your patient’s access to Paxlovid?
How confident are you in recommending pre-emptive COVID-19 antiviral treatment for your high-risk patients in the event they test positive in the community?
Moving forward, how many COVID-19 pre-emptive treatment consultations do you think you will have with your high-risk pharmacy patients per week?